Published in Eur J Biochem on June 01, 1996
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45
Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol (2012) 3.21
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19
Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J (1999) 2.93
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One (2010) 2.78
Epithelial antimicrobial peptides in host defense against infection. Respir Res (2000) 2.40
The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun (1999) 2.35
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut (2003) 1.97
The innate immune system in cystic fibrosis lung disease. J Clin Invest (1999) 1.93
Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology (2006) 1.88
Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun (1999) 1.87
Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun (2002) 1.80
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A (2006) 1.75
Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother (2010) 1.74
Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest (2002) 1.67
Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun (2005) 1.60
Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37. Proc Natl Acad Sci U S A (2011) 1.48
Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection. Infect Immun (2006) 1.41
Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog (2010) 1.41
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs (2011) 1.39
Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2007) 1.33
The role of antimicrobial peptides at the ocular surface. Ophthalmic Res (2008) 1.32
The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun (2000) 1.30
Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother (2005) 1.28
Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun (2005) 1.24
Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 1.23
Phenylbutyrate induces antimicrobial peptide expression. Antimicrob Agents Chemother (2009) 1.21
Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. J Immunol (2012) 1.20
Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res (2008) 1.19
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob Agents Chemother (2008) 1.16
Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. J Immunol (2010) 1.15
The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol (2010) 1.12
Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J (2005) 1.11
Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother (2008) 1.11
A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog (2011) 1.10
Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast Cancer Res (2009) 1.10
Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int J Cancer (2010) 1.09
High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta (2014) 1.05
Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection. Infect Immun (2000) 1.05
Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes. Eur Biophys J (2003) 1.04
The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. J Immunol (2009) 1.04
Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses. J Clin Invest (2014) 1.03
Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol (2012) 1.03
Structure and mechanism of beta-hairpin antimicrobial peptides in lipid bilayers from solid-state NMR spectroscopy. Mol Biosyst (2009) 1.00
Intestinal barrier in inflammatory bowel disease. World J Gastroenterol (2014) 0.97
Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms. J Biol Chem (2012) 0.97
Peptide-based Antifungal Therapies against Emerging Infections. Drugs Future (2010) 0.97
Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon. Microbiology (2009) 0.96
Mechanisms and fitness costs of resistance to antimicrobial peptides LL-37, CNY100HL and wheat germ histones. PLoS One (2013) 0.96
Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol (2008) 0.95
LL-37 as a therapeutic target for late stage prostate cancer. Prostate (2010) 0.95
The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease. PLoS One (2012) 0.94
Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect Immun (1999) 0.94
cAMP stringently regulates human cathelicidin antimicrobial peptide expression in the mucosal epithelial cells by activating cAMP-response element-binding protein, AP-1, and inducible cAMP early repressor. J Biol Chem (2009) 0.93
Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans. Infect Immun (2010) 0.93
Antimicrobial peptides and colitis. Curr Pharm Des (2013) 0.91
Microbial amyloids--functions and interactions within the host. Curr Opin Microbiol (2013) 0.91
Two cathelicidin genes are present in both rainbow trout (Oncorhynchus mykiss) and atlantic salmon (Salmo salar). Antimicrob Agents Chemother (2006) 0.91
Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology. Semin Immunopathol (2013) 0.91
Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice. J Immunol (2013) 0.89
A comparative study on the interactions of SMAP-29 with lipid monolayers. Biochim Biophys Acta (2009) 0.88
High-yield expression of isotopically labeled peptides for use in NMR studies. Protein Sci (2003) 0.88
Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo. PLoS One (2014) 0.88
Cationic antimicrobial peptides serve as activation signals for the Salmonella Typhimurium PhoPQ and PmrAB regulons in vitro and in vivo. Front Cell Infect Microbiol (2012) 0.87
Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC Cardiovasc Disord (2006) 0.87
IL-17A and IFN-γ synergistically induce RNase 7 expression via STAT3 in primary keratinocytes. PLoS One (2013) 0.87
Expression of CRAMP via PGN-TLR-2 and of alpha-defensin-3 via CpG-ODN-TLR-9 in corneal fibroblasts. Br J Ophthalmol (2006) 0.86
Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance. Infect Immun (2009) 0.86
Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparation. Antimicrob Agents Chemother (2004) 0.86
Enhanced resistance to bacterial and fungal pathogens by overexpression of a human cathelicidin antimicrobial peptide (hCAP18/LL-37) in Chinese cabbage. Plant Biotechnol Rep (2011) 0.86
Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease. J Invest Dermatol (2011) 0.85
The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes. Antimicrob Agents Chemother (2008) 0.85
Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing. Infect Immun (2011) 0.85
Epithelial antimicrobial peptides: guardian of the oral cavity. Int J Pept (2014) 0.85
Interleukin-8-derived peptide has antibacterial activity. Antimicrob Agents Chemother (2005) 0.84
Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37. RSC Adv (2013) 0.83
Cathelicidin gene expression in porcine tissues: roles in ontogeny and tissue specificity. Infect Immun (1999) 0.83
Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors. Sci Rep (2016) 0.83
Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages. Autophagy (2015) 0.82
Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa. PLoS One (2013) 0.82
Lactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasis. PLoS One (2013) 0.82
Anisotropic Membrane Curvature Sensing by Amphipathic Peptides. Biophys J (2016) 0.81
Substrate specificity of a peptidyl-aminoacyl-L/D-isomerase from frog skin. Amino Acids (2011) 0.80
Modulation of neutrophil apoptosis by antimicrobial peptides. ISRN Microbiol (2012) 0.80
No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis. PLoS One (2014) 0.80
Effect of intracellular expression of antimicrobial peptide LL-37 on growth of escherichia coli strain TOP10 under aerobic and anaerobic conditions. Antimicrob Agents Chemother (2013) 0.80
Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections. Pathog Glob Health (2016) 0.80
Characterizing the role of cell-wall β-1,3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37. PLoS One (2011) 0.79
Trans-species polymorphism at antimicrobial innate immunity cathelicidin genes of Atlantic cod and related species. PeerJ (2015) 0.79
Therapeutic approaches using host defence peptides to tackle herpes virus infections. Viruses (2009) 0.78
Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR modulation, chemokine induction and regulation of phagocytosis. Sci Rep (2017) 0.77
Anti-adenoviral effects of human cationic antimicrobial protein-18/LL-37, an antimicrobial peptide, by quantitative polymerase chain reaction. Korean J Ophthalmol (2013) 0.77
Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules? Front Immunol (2012) 0.77
Regulation of the Intestinal Barrier Function by Host Defense Peptides. Front Vet Sci (2015) 0.76
LL37:DNA complexes provide antimicrobial activity against intracellular bacteria in human macrophages. Immunology (2016) 0.76
Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37. J Biol Chem (2015) 0.76
Cathelicidins in the Tasmanian devil (Sarcophilus harrisii). Sci Rep (2016) 0.76
Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective. BMJ (1992) 5.87
The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol Microbiol (1990) 5.09
Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. Antimicrob Agents Chemother (1976) 4.64
Modulation of virulence factor expression by pathogen target cell contact. Science (1996) 3.99
The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82
Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol (2001) 3.39
Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol (1999) 3.28
Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med (2001) 3.11
The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood (2000) 3.09
Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J (1999) 2.93
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem (1998) 2.91
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A (1995) 2.89
YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect Immun (1993) 2.63
Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J (2000) 2.59
Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun (1993) 2.37
Validation of a composite score for clinical severity of hemophilia. J Thromb Haemost (2008) 2.33
Eye contact and face scanning in early infancy. Science (1977) 2.20
Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.15
Dog saliva - an important source of dog allergens. Allergy (2013) 2.00
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut (2003) 1.97
Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem (1991) 1.95
Effect of patients' expectations on recovery from acute tonsillitis. Fam Pract (1989) 1.90
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett (1999) 1.68
Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. Eur J Biochem (1987) 1.67
Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem (1998) 1.57
The childbirth experience: a study of 295 new mothers. Birth (1996) 1.56
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis. Med Microbiol Immunol (1977) 1.55
Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis. Scand J Infect Dis (1975) 1.54
Further studies on fecal parasites in antiquity. Am J Clin Pathol (1999) 1.53
Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods (1999) 1.40
Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med (1999) 1.37
Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem (1988) 1.34
Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett (1999) 1.34
Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem (1996) 1.32
Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J Immunol (1997) 1.31
Cloning, overexpression, and characterization of glutaredoxin 2, an atypical glutaredoxin from Escherichia coli. J Biol Chem (1997) 1.28
Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci U S A (1995) 1.26
95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. Proc Natl Acad Sci U S A (1988) 1.26
Identification of the phosphorylation site for cAMP-dependent protein kinase on Na+,K(+)-ATPase and effects of site-directed mutagenesis. J Biol Chem (1994) 1.21
Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke (1994) 1.19
S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment. Eur J Biochem (1994) 1.19
Diagnosis of pulmonary tuberculosis by selected-ion monitoring: improved analysis of tuberculostearate in sputum using negative-ion mass spectrometry. J Clin Microbiol (1987) 1.19
Human pharmacokinetics of iohexol. A new nonionic contrast medium. Invest Radiol (1983) 1.19
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol (2000) 1.18
A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. Cellular distribution and molecular characterization of the antigen. J Immunol (1991) 1.18
Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions. Cell Mol Life Sci (2005) 1.18
Some properties of coagulase-negative deoxyribonuclease-producing strains of staphylococci from human infections. Med Microbiol Immunol (1976) 1.16
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med (2005) 1.15
Activation of the anaerobic ribonucleotide reductase from Escherichia coli. The essential role of the iron-sulfur center for S-adenosylmethionine reduction. J Biol Chem (1997) 1.14
Fast horizontal electrophoresis. I. Isoelectric focusing and polyacrylamide gel electrophoresis using PhastSystem. Electrophoresis (1988) 1.12
Further improved method for measuring monophasic action potentials of the intact human heart. J Electrocardiol (1971) 1.10
The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br J Dermatol (2002) 1.10
Effects of calcium hydroxide and sodium hypochlorite on the dissolution of necrotic porcine muscle tissue. J Endod (1988) 1.10
Recovery of gel-separated proteins for in-solution digestion and mass spectrometry. Anal Chem (2001) 1.09
Both risk alleles for FcgammaRIIA and FcgammaRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun (2004) 1.08
[The perspective of primary health care in programs for whiplash injuries is not visible]. Lakartidningen (1998) 1.07
Validity and reproducibility of determination of cardiac output by thermodilution in man. Cardiology (1970) 1.07
Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia (1998) 1.07
Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem (1996) 1.06
Effects of balance training in elderly evaluated by clinical tests and dynamic posturography. J Vestib Res (1994) 1.04
Adenocarcinoid of the vermiform appendix. Virchows Arch A Pathol Anat Histol (1980) 1.03
Medium- and short-chain dehydrogenase/reductase gene and protein families : The role of zinc for alcohol dehydrogenase structure and function. Cell Mol Life Sci (2008) 1.03
Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. Biochem Biophys Res Commun (2000) 1.03
The molecular chaperonin TF55 from the Thermophilic archaeon Sulfolobus solfataricus. A biochemical and structural characterization. J Mol Biol (1994) 1.03
Ventilation/Perfusion SPECT for diagnostics of pulmonary embolism in clinical practice. J Intern Med (2008) 1.03
Genotyping by apyrase-mediated allele-specific extension. Nucleic Acids Res (2001) 1.01
Isolation, characterization, and primary structure of a calcium-binding 63-kDa bone protein. J Biol Chem (1995) 1.00
Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide. Eur J Biochem (1994) 1.00
Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for innate antimicrobial peptides. Cell Mol Life Sci (2003) 0.99
Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes (1989) 0.99
Subcutaneous implantation for the biological evaluation of endodontic materials. J Endod (1981) 0.99
Behavioral observations concerning differential diagnosis between the Rett syndrome and autism. Brain Dev (1985) 0.98
Glutaredoxin-3 from Escherichia coli. Amino acid sequence, 1H AND 15N NMR assignments, and structural analysis. J Biol Chem (1996) 0.98
The relationship between the bacterium Streptococcus mutans in the saliva and dental caries in children in Mozambique. Arch Oral Biol (1985) 0.97
Follow-up study of endodontic status in an adult Swedish population. Endod Dent Traumatol (1991) 0.97
UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females. Eur J Clin Pharmacol (2006) 0.96
Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Lett (1986) 0.96
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol (2000) 0.96
Molecular cloning, heterologous expression, and characterization of human glyoxalase II. J Biol Chem (1996) 0.95
Vascular function and blood pressure in GH transgenic mice. Endocrinology (2001) 0.95
Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis (1994) 0.95
Optimized alcoholytic deacetylation of N-acetyl-blocked polypeptides for subsequent Edman degradation. Anal Biochem (1997) 0.94
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am J Physiol Endocrinol Metab (2001) 0.93
Technical quality of root fillings in an adult Swedish population. Endod Dent Traumatol (1986) 0.93
Possible release of an ArgGlyArgProGln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal streptococcus and actinomyces species. Infect Immun (2000) 0.92
beta-lactamases in bacteroides. Scand J Infect Dis Suppl (1978) 0.92
Galanin receptor and its ligands in the rat hippocampus. Eur J Biochem (1989) 0.92
Antibodies with specificities against a dispase-produced 15-kilodalton hexon fragment neutralize adenovirus type 2 infectivity. J Virol (1990) 0.92
Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunol (1996) 0.91
Heterologous expression of rat liver microsomal glutathione transferase in simian COS cells and Escherichia coli. Biochem J (1995) 0.91
Identification of gel-separated tumor marker proteins by mass spectrometry. Electrophoresis (2000) 0.91
Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics. Cell Mol Life Sci (2000) 0.90
Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors. J Thromb Haemost (2015) 0.90
High prevalence of mutans streptococci in a population with extremely low prevalence of dental caries. Oral Microbiol Immunol (1987) 0.89
Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis Rheum (2004) 0.89